Manuela Cominelli

发表

Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer

M. Memo, G. Tiberio, P. L. Poliani, 2021, Frontiers in Endocrinology.

Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and - independent cellular responses in Alzheimer’s disease

Maxim N. Artyomov, D. Bennett, D. Holtzman, 2019, Nature Medicine.

β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice

S. Calza, P. L. Poliani, M. Presta, 2022, International journal of molecular sciences.

Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme.

M. Cenzato, A. Padovani, P. L. Poliani, 2013, Neuro-oncology.

Cancer esearch cular and Cellular Pathobiology ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required R Gliomagenesis

A. Falini, R. Galli, A. Franzin, 2010 .

Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System

P. Dell’Era, P. L. Poliani, N. Steimberg, 2023, Biomedicines.

Treatment with anti-FcεRIα antibody exacerbates EAE and T-cell immunity against myelin

R. Pedotti, L. Steinman, G. Abolafio, 2017, Neurology: Neuroimmunology & Neuroinflammation.

EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.

G. Finocchiaro, R. Galli, P. Dalerba, 2015, Journal of the National Cancer Institute.

Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.

J. García-Verdugo, L. Leocani, M. Cursi, 2011, Cell stem cell.

Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma.

E. Monti, P. L. Poliani, M. Colombi, 2016, European journal of cell biology.

Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease

D. Holtzman, D. Bennett, A. Kakita, 2020, Nature Medicine.

Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.

P. L. Poliani, A. Villa, P. Vezzoni, 2012, Blood.

Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma

G. Finocchiaro, B. Pollo, S. Pellegatta, 2019, International journal of cancer.

Altered function of the glutamate aspartate transporter GLAST in glioblastoma

G. Finocchiaro, B. Pollo, S. Pellegatta, 2018, bioRxiv.

Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas

M. Rehli, Julian Taranda, P. L. Poliani, 2023, Cell reports. Medicine.

The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1

A. Falini, R. Galli, A. Molinari, 2018, Cell Death & Differentiation.

Phosphocaveolin-1 Enforces Tumor Growth and Chemoresistance in Rhabdomyosarcoma

S. Calza, E. Monti, M. Sampaolesi, 2014, PloS one.

Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis.

R. Galli, P. L. Poliani, L. Politi, 2010, Cancer research.

Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas.

D. Garbossa, G. Finocchiaro, A. Melcarne, 2023, Cell reports.

A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes

R. Galli, C. Isella, E. Medico, 2020, Laboratory Investigation.

MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells

G. Finocchiaro, P. Comoglio, S. Pellegatta, 2016, EMBO molecular medicine.

EBF1 is expressed in pericytes and contributes to pericyte cell commitment

P. Dell’Era, P. L. Poliani, M. Cominelli, 2021, Histochemistry and Cell Biology.

Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis

A. Falini, R. Galli, A. Castellano, 2019, Neurobiology of Disease.

Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line

F. Doglietto, P. L. Poliani, P. Nicolai, 2023, Journal of personalized medicine.

mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma

A. Falini, B. Pollo, R. Galli, 2021, JCI insight.

Cavin-2 is a specific marker for detection of well-differentiated liposarcoma.

E. Monti, P. L. Poliani, A. Fanzani, 2017, Biochemical and biophysical research communications.

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma.

A. Falini, R. Galli, A. Castellano, 2022, Cancer Research.

Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma.

E. Monti, P. L. Poliani, A. Fanzani, 2011, European journal of cancer.

MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line

C. Keller, E. Monti, R. Parton, 2015, PloS one.

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration

G. Finocchiaro, V. Frattini, S. Pellegatta, 2012, Oncotarget.

miR‐135a Inhibits Cancer Stem Cell‐Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression

F. Speleman, R. Galli, R. Maestro, 2015, Stem cells.

Gene signatures associated with mouse postnatal hindbrain neural stem cells and medulloblastoma cancer stem cells identify novel molecular mediators and predict human medulloblastoma molecular classification.

F. Rossi, R. Galli, P. Rossi, 2012, Cancer discovery.

cancer stem cells identify novel molecular mediators and predict human MB molecular classification.

F. Rossi, R. Galli, P. Rossi, 2012 .

ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required

A. Falini, R. Galli, A. Franzin, 2010 .

Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models

L. Leocani, M. Cursi, R. Galli, 2013, Disease Models & Mechanisms.